LiberoThera Co., Ltd. contribute to medical care through innovative drug discovery using the technologies of cell-free membrane protein preparation and non-natural amino acid introduction.
Investors 3
| Date | Name | Website |
| - | Beyond Nex... | beyondnext... |
| 26.11.2021 | Taiho Vent... | taihoventu... |
| - | MP Healthc... | mp-healthc... |
Mentions in press and media 4
| Date | Title | Description |
| 01.08.2024 | Decided to make additional investment in Liberocera Co., Ltd. | Decided to make additional investment in Liberocera Co., Ltd. *Tokyo University IPC* Press release: August 1, 2024 Decided to make additional investment in Liberocera Co., Ltd. The University of Tokyo Collaborative Platform Development Co.,... |
| 01.08.2024 | Decided to make additional investment in Liberocera Co., Ltd. | - |
| 26.05.2021 | BGC Announces Agreement to Sell its Insurance Brokerage Business to The Ardonagh Group for $500 Million USA - English USA - English Nederland - Nederlands France - Français Deutschland - Deutsch Lati... | |
| - | Libero Thera | “We contribute to medical care through innovative drug discovery using cell membrane-free protein preparation technology and unnatural amino acid introduction technology. - We are conducting drug discovery mainly in antibody drugs targeting... |